Home › Funds › Renaissance Technologies › CPRX
Renaissance Technologies position in CPRX
CATALYST PHARMACEUTICALS INC
Latest position (Q2 2026)2.14M sh
Reported value held$67.14M
Portfolio Weight0.09%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 52.24K | $277.00K | New |
| Q4 2021 | 422.89K | $2.86M | Add |
| Q1 2022 | 353.11K | $2.93M | Reduce |
| Q2 2022 | 1.03M | $7.23M | Add |
| Q3 2022 | 2.23M | $28.57M | Add |
| Q4 2022 | 1.23M | $22.91K | Reduce |
| Q1 2023 | 1.09M | $18.07K | Reduce |
| Q2 2023 | 1.15M | $15.52K | Add |
| Q3 2023 | 1.29M | $15.07K | Add |
| Q4 2023 | 1.60M | $26.85K | Add |
| Q1 2024 | 1.89M | $30.10K | Add |
| Q2 2024 | 2.18M | $33.70M | Add |
| Q3 2024 | 2.53M | $50.22M | Add |
| Q4 2024 | 2.71M | $56.48M | Add |
| Q1 2025 | 2.96M | $71.69M | Add |
| Q1 2025 | 2.96M | $71.69M | Add |
| Q2 2025 | 3.25M | $70.56M | Add |
| Q2 2025 | 3.25M | $70.56M | Add |
| Q3 2025 | 3.54M | $69.83M | Add |
| Q4 2025 | 2.65M | $61.85M | Reduce |
| Q1 2026 | 2.35M | $58.12M | Reduce |
| Q2 2026 | 2.14M | $67.14M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CPRX
- BlackRock Inc 19.16M sh · $602.16M · Q2 2026
- Vanguard Group 8.43M sh · $196.81M · Q4 2025
- JPMorgan Chase & Co 3.17M sh · $99.89M · Q2 2026
- Geode Capital Management 3.15M sh · $99.03M · Q2 2026
- Morgan Stanley 2.76M sh · $86.76M · Q2 2026
- Janus Henderson Group 2.00M sh · $49.52M · Q1 2026
- UBS Group AG 1.45M sh · $45.69M · Q2 2026
- Northern Trust Corp 1.33M sh · $41.82M · Q2 2026
- Bank of America Corp 1.31M sh · $41.22M · Q2 2026
- Goldman Sachs Group 1.19M sh · $37.53M · Q2 2026
- Charles Schwab Investment Management 1.16M sh · $36.44M · Q2 2026